Genome analysis and characterisation of the exopolysaccharide produced by Bifidobacterium longum subsp. longum 35624™
dc.contributor.author | Altmann, Friedrich | |
dc.contributor.author | Kosma, Paul | |
dc.contributor.author | O'Callaghan, Amy | |
dc.contributor.author | Leahy, Sinead C. | |
dc.contributor.author | Bottacini, Francesca | |
dc.contributor.author | Molloy, Evelyn M. | |
dc.contributor.author | Plattner, Stephan | |
dc.contributor.author | Schiavi, Elisa | |
dc.contributor.author | Gleinser, Marita | |
dc.contributor.author | Groeger, David S. | |
dc.contributor.author | Grant, Ray | |
dc.contributor.author | Rodriguez Perez, Noelia | |
dc.contributor.author | Healy, Selena | |
dc.contributor.author | Svehla, Elisabeth | |
dc.contributor.author | Windwarder, Markus | |
dc.contributor.author | Hofinger, Andreas | |
dc.contributor.author | O'Connell Motherway, Mary | |
dc.contributor.author | Akdis, Cezmi A. | |
dc.contributor.author | Xu, Jun | |
dc.contributor.author | Roper, Jennifer | |
dc.contributor.author | van Sinderen, Douwe | |
dc.contributor.author | O'Mahony, Liam | |
dc.contributor.funder | Health Research Board | en |
dc.contributor.funder | Irish Research Council for Science, Engineering and Technology | en |
dc.contributor.funder | Science Foundation Ireland | en |
dc.contributor.funder | European Commission | en |
dc.contributor.funder | Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | en |
dc.contributor.funder | Alimentary Health Pharma Davos, Switzerland | en |
dc.contributor.funder | Christine Kühne Center for Allergy Research and Education, Switzerland | en |
dc.contributor.funder | Procter & Gamble, United States. | en |
dc.date.accessioned | 2016-10-06T11:55:44Z | |
dc.date.available | 2016-10-06T11:55:44Z | |
dc.date.issued | 2016-09-22 | |
dc.description.abstract | The Bifibobacterium longum subsp. longum 35624™ strain (formerly named Bifidobacterium longum subsp. infantis) is a well described probiotic with clinical efficacy in Irritable Bowel Syndrome clinical trials and induces immunoregulatory effects in mice and in humans. This paper presents (a) the genome sequence of the organism allowing the assignment to its correct subspeciation longum; (b) a comparative genome assessment with other B. longum strains and (c) the molecular structure of the 35624 exopolysaccharide (EPS624). Comparative genome analysis of the 35624 strain with other B. longum strains determined that the sub-speciation of the strain is longum and revealed the presence of a 35624-specific gene cluster, predicted to encode the biosynthetic machinery for EPS624. Following isolation and acid treatment of the EPS, its chemical structure was determined using gas and liquid chromatography for sugar constituent and linkage analysis, electrospray and matrix assisted laser desorption ionization mass spectrometry for sequencing and NMR. The EPS consists of a branched hexasaccharide repeating unit containing two galactose and two glucose moieties, galacturonic acid and the unusual sugar 6-deoxy-L-talose. These data demonstrate that the B. longum 35624 strain has specific genetic features, one of which leads to the generation of a characteristic exopolysaccharide. | en |
dc.description.sponsorship | European Commission (European Union Marie Curie training network, “TEAM-EPIC”); Swiss National Science Foundation (Grants project numbers CRSII3_154488 and 310030_144219); Christine Kühne Center for Allergy Research and Education; Science Foundation Ireland (SFI Grant No. SFI/12/RC/2273); Irish Research Council (Enterprise partnership scheme); Health Research Board (HRB postdoctoral fellowship (Grant No. PDTM/20011/9)); Alimentary Health Pharma Davos; Procter & Gamble, United States. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Altmann F., Kosma P., O’Callaghan A., Leahy S., Bottacini F. et al (2016) ‘Genome analysis and characterisation of the exopolysaccharide produced by Bifidobacterium longum subsp. longum 35624™,’ PLoS ONE 11(9): e0162983 (23pp). doi: 10.1371/journal.pone.0162983 | en |
dc.identifier.doi | 10.1371/journal.pone.0162983 | |
dc.identifier.endpage | e0162983-23 | en |
dc.identifier.issn | 1932-6203 | |
dc.identifier.issued | 9 | en |
dc.identifier.journaltitle | PLoS ONE | en |
dc.identifier.startpage | e0162983-1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/3164 | |
dc.identifier.volume | 11 | en |
dc.language.iso | en | en |
dc.publisher | Public Library of Science | en |
dc.rights | © 2016 Altmann et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Exopolysaccharides | en |
dc.subject | Bifidobacterium | en |
dc.subject | Comparative genomics | en |
dc.subject | Protons | en |
dc.subject | Monosaccharides | en |
dc.subject | NMR spectroscopy | en |
dc.subject | Gene prediction | en |
dc.subject | Polysaccharides | en |
dc.title | Genome analysis and characterisation of the exopolysaccharide produced by Bifidobacterium longum subsp. longum 35624™ | en |
dc.type | Article (peer-reviewed) | en |